v3.20.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenues:    
Total Revenues $ 31,243 $ 186,552
Selling, general and administrative expenses 4,911,613 6,482,953
Research and development expenses 2,206,120 1,238,749
Loss on impairment of intangible asset 588,822 319,635
Loss from Operations (7,675,312) (7,854,785)
Other (Income) Expense:    
Amortization of debt discount 6,562,736
Gain on extinguishment of convertible notes payable (1,481,317)
Interest (income) expense, net (49,915) 298,161
Change in fair value of derivative liabilities (191,656)
Total Other (Income) Expense (49,915) 5,187,924
Net Loss (7,625,397) (13,042,709)
Deemed dividend to preferred stockholders (3,310,001)
Net Loss Attributable to Common Stockholders $ (7,625,397) $ (16,352,710)
Net Loss Per Basic and Diluted Common Share: $ (0.48) $ (1.75)
Weighted Average Number of Common Shares Outstanding: Basic and Diluted 15,760,444 9,362,474
Royalty Income [Member]    
Revenues:    
Total Revenues $ 31,243 $ 116,152
Contract Research - Related Party [Member]    
Revenues:    
Total Revenues $ 70,400

Source